Physician profile
Mitul Patel
NPI 1457572448
$602,228.06
in general payments reported to CMS, 2019-2025
38 companies · $257K in 2025
The $257K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $35K · 2021: $33K · 2022: $65K · 2023: $60K · 2024: $92K · 2025: $257K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $210K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Consulting Fee: $37K · Honoraria: $35K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Travel and Lodging: $16K · Food and Beverage: $15K · Grant: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $210,432.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,175.00 |
| Consulting Fee | $36,575.00 |
| Honoraria | $35,150.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $23,400.00 |
| Travel and Lodging | $15,671.12 |
| Food and Beverage | $15,009.45 |
| Grant | $470.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $248,865.58 | 2019-2025 | General - Therapies, General - Vascular Access, Wolverine Coronary Cutting Balloon |
| Shockwave Medical, INC | $67,839.09 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $66,212.30 | 2019-2025 | Impella |
| Medtronic, INC. | $66,083.03 | 2021-2024 | Onyx Frontier, Resolute Onyx, Venaseal |
| Abbott Laboratories | $33,825.30 | 2019-2023 | Diamondback Coronary |
| Chiesi USA, INC. | $32,828.24 | 2019-2024 | Kengreal |
| Terumo Medical Corporation | $23,912.43 | 2019-2024 | Glidewire, Optitorque, Metacross Otw |
| Cardiovascular Systems INC. | $20,574.55 | 2019-2022 | |
| Inari Medical, INC. | $14,254.80 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $10,844.95 | 2019-2020 | |
| Stryker Corporation | $4,379.91 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Microvention, INC. | $3,331.53 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $2,882.71 | 2019-2022 | |
| Neptune Medical INC. | $2,814.10 | 2023-2024 | |
| Biotronik INC. | $624.49 | 2019-2025 | Orsiro Mission, Trapit, Nhancer Rx |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $554.20 | 2019-2024 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Reflow Medical INC | $271.90 | 2024-2025 | |
| Asahi Intecc USA, INC. | $242.08 | 2022-2025 | Asahi Peripheral Vascular Wires, Asahi Ptca Guide Wire |
| Philips North America LLC | $232.58 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $219.51 | 2022 | |
| Corindus INC. | $206.10 | 2019 | |
| Impulse Dynamics (USA) INC. | $177.59 | 2023 | Optimizer |
| Avinger INC. | $170.25 | 2019-2021 | |
| Acist Medical Systems, INC. | $167.01 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.15 | 2020-2022 | |
| Cvrx, INC. | $144.75 | 2021 | |
| Cordis US Corp. | $117.33 | 2024-2025 | Mynx Control Venous, Infiniti |
| Balt USA, LLC | $65.76 | 2022 | |
| Allergan, INC. | $50.04 | 2019 | |
| Getinge USA Sales, LLC | $43.93 | 2023 | Cardiohelp |
| Walk Vascular, LLC | $36.81 | 2020 | |
| Cook Medical LLC | $27.04 | 2019 | |
| Glaxosmithkline, LLC. | $24.87 | 2019 | |
| Janssen Scientific Affairs, LLC | $20.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.55 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.10 | 2023 | Farxiga |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,650.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$49,998.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.